Skip to content

The Effect of Olive Leaf Extract Supplementation on Training-induced Skeletal Muscle Functional and Molecular Adaptations in Healthy Volunteers

The Effect of Olive Leaf Extract Supplementation on Training-induced Skeletal Muscle Functional and Molecular Adaptations in Healthy Volunteers

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07729072
Acronym
OLE_Training_1
Enrollment
60
Registered
2026-07-27
Start date
2026-09-01
Completion date
2029-12-31
Last updated
2026-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise Training, Healthy Adult Participants, Neuromuscular Adaptations, Nutritional Intervention

Keywords

exercise, mitochondria, knee extensors, performance

Brief summary

The goal of this study is to investigate the effect of combining olive leaf extract supplementation with endurance training (moderate intensity continuous training or sprint interval training). We hypothesize that OLE supplementation during training, as compared to training alone with placebo, will translate into better performance outcomes. More specifically, we hypothesize that the additional benefits of OLE supplementation on performance will be mediated by improved mitochondrial characteristics in skeletal muscle and increased neural activation.

Detailed description

Maximal exercise capacity (VO2peak) predicts cardiovascular risk and all-cause mortality. Regular moderate to vigorous physical activity, a key determinant of VO2peak, is essential for an optimal health status of the general population. Thus, strategies that accentuate the health benefits of exercise may have considerable therapeutic benefits. Skeletal muscle Ca2+ handling is a primary determinant of exercise capacity. The regulation of skeletal muscle contraction by Ca2+ is coupled to mitochondrial energy production through a mechanism involving transport across the inner mitochondrial membrane by the mitochondrial Ca2+ uniporter (MCU). Ca2+ entry in the mitochondrial matrix controls Ca2+ -sensitive enzymes, including pyruvate dehydrogenase (PDH) activity, a rate-limiting enzyme for glycolysis. Olive leaf extract (OLE) contains \ 40% of the natural polyphenol oleuropein and is a potent activator of MCU in skeletal muscle with anti-inflammatory and antioxidant properties. The present study will be a double-blind, randomized, placebo-controlled, parallel study in healthy young individuals (18-45 years) consisting of a 3-week endurance training (either moderate intensity continuous training or sprint interval training) period combined with OLE or placebo intake. We will examine the impact of OLE supplementation on maximal exercise capacity, knee extensor neuromuscular function, muscular and blood adaptations. The results of this study will elucidate whether OLE supplementation improves fitness parameters and the molecular mechanisms regulating these adaptations.

Interventions

DIETARY_SUPPLEMENTOlive leaf extract

A capsule containing 250 mg of an olive leaf extract preparation will be swallowed with a glass of water daily for 21 days.

DIETARY_SUPPLEMENTPlacebo

A capsule containing 336 mg of cellulose microcrystalline will be swallowed with a glass of water daily for 21 days.

Sponsors

University of Lausanne
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

The CHUV pharmacy will perform the randomization.

Intervention model description

The design is a double-blind, randomized, placebo-controlled, parallel study.

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

1. Being between 18 and 45 years old 2. Being healthy (assessed through the PAR-Q questionnaire). 3. Being physically active, but not involved in any structured training program 4. Being available for the study period.

Exclusion criteria

1. If a participant answers positively to any YES/NO question in the PAR-Q health questionnaire. For questions requiring a precision, any positive answer will be reviewed by a medical doctor, who will determine the inclusion/exclusion of the participant. 2. Having allergy to xylocaine 3. Being pregnant.

Design outcomes

Primary

MeasureTime frameDescription
maximal aerobic powerbefore and after the three-week training periodmaximal power (in watts) measured during a graded exercise to failure

Secondary

MeasureTime frameDescription
Maximal oxygen uptakebefore and after the three-week training periodmaximal oxygen uptake (ml/min/kg) measured during a graded exercise until failure
Submaximal heart rate and powerbefore and after the three-week training periodheart rate and power measured during submaximal cycling exercise
Knee extensor neuromuscular functionbefore and after the three-week training periodmaximal voluntary contraction force and maximal voluntary activation level

Countries

Switzerland

Contacts

CONTACTNicolas Place, PhD
nicolas.place@unil.ch+41216923806

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 28, 2026